Skip to main content
Clinical Trials/NCT00989820
NCT00989820
Terminated
Phase 2

Efficacy of Adding Hyperbaric Oxygen Therapy to the Treatment of Late Radiation Damage of the Lower Jaw (Osteoradionecrosis).

Radboud University Medical Center8 sites in 1 country20 target enrollmentOctober 1, 2009

Overview

Phase
Phase 2
Intervention
hyperbaric oxygen
Conditions
Osteoradionecrosis
Sponsor
Radboud University Medical Center
Enrollment
20
Locations
8
Primary Endpoint
absence of exposed bone, fistulae or ulceration.
Status
Terminated
Last Updated
7 months ago

Overview

Brief Summary

The purpose of this study is to determine whether hyperbaric oxygen therapy is effective in the treatment of osteoradionecrosis (late complication of radiation therapy) of the jaw.

Detailed Description

Damage to the lower jaw as a late complication of radiation therapy (osteoradionecrosis (ORN)) is often seen in patients treated with radiation therapy for a tumor in the head and neck region. Part of the lower jaw becomes non-vital and has to be treated. ORN proofs to be a condition difficult to treat and the treatment for this condition varies. In many countries hyperbaric oxygen therapy (HBOT) is added to the surgical treatment of ORN. Unfortunately there is no consensus whether the addition of hyperbaric oxygen therapy to the treatment of ORN is beneficial or not. This study has the aim to investigate the efficacy and cost-effectiveness of HBOT in the treatment of ORN.

Registry
clinicaltrials.gov
Start Date
October 1, 2009
End Date
March 1, 2020
Last Updated
7 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Informed consent
  • Age ≥ 18 jr
  • WHO performance status 0-2
  • Last radiation treatment ≥ 6 month ago radiotherapy with curative intention and \> 55 Gy. The affected part of the jaw must be in the target volume area of the radiotherapy field.
  • Local recurrence must be ruled out
  • Necrosis of the jaw with at least one of the following symptoms for over 3 month present:
  • Bone exposition which measures at least 1 cm
  • Evident bone lesions at radiologic evaluation (panorex) that fits the diagnosis ORN.
  • Non-healing extraction socket

Exclusion Criteria

  • Former HBO treatment
  • Contra indication for HBO treatment (pneumothorax)
  • Bisphosphonate treatment in the medical history
  • reirradiation in the medical history
  • Osteosynthesis material in the affected area
  • Distant metastasis
  • Primary or recurrent tumor in the affected area
  • Malignancies elsewhere

Arms & Interventions

Hyperbaric oxygen therapy with surgery

Intervention arm. Hyperbaric oxygen therapy with surgery.

Intervention: hyperbaric oxygen

Outcomes

Primary Outcomes

absence of exposed bone, fistulae or ulceration.

Time Frame: 12 months after finishing therapy in the arm assigned to

Number of patients with complete healing

Secondary Outcomes

  • Pain score(one year after therapy in the arm assigned to.)
  • Clinical and radiological assessment of the treatment response(one year after therapy in the arm assigned to.)
  • Completion of the therapy in the arm for which patient has been randomized; if someone drops out of this study the reason will be scored.(one year after therapy in the arm assigned to.)
  • Use of pain medication(one year after therapy in the arm assigned to.)
  • Type of surgical intervention(one year after therapy in the arm assigned to.)
  • Quality of life(one year after therapy in the arm assigned to.)
  • Cost effectiveness(one year after therapy in the arm assigned to.)

Study Sites (8)

Loading locations...

Similar Trials